Top compounds associated with response to RP13-347D8.7


Feature Type Standardized
Nominal ANOVA
mRNA erlotinib:PLX-4032 (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.15 2e-05
mRNA manumycin A CTRPv2 pan-cancer AAC 0.13 4e-05
mRNA L-685458 CTRPv2 pan-cancer AAC 0.14 6e-05
mRNA staurosporine CTRPv2 pan-cancer AAC 0.29 8e-05
mRNA BRD-K27188169:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.2 9e-05
mRNA GW843682X CTRPv2 pan-cancer AAC 0.13 0.0001
mRNA ibrutinib CTRPv2 pan-cancer AAC 0.15 0.0002
mRNA MK 1775 CTRPv2 pan-cancer AAC 0.12 0.0002
mRNA BRD-K63431240 CTRPv2 pan-cancer AAC 0.13 0.0003
mRNA etoposide CTRPv2 pan-cancer AAC 0.098 0.0007
Download CSV